Neupogen Alternatives Compared
| Neupogen (filgrastim) | Filgrastim | Zarxio (filgrastim) |
|
|---|
| Neupogen (filgrastim) | Filgrastim | Zarxio (filgrastim) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy, Neutropenia, Peripheral Progenitor Cell Transplantation, Bone Marrow Transplantation, Neutropenia Associated with Radiation, Hematopoietic... View more |
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy, Neutropenia, Aplastic Anemia, Peripheral Progenitor Cell Transplantation, Bone Marrow Transplantation, Neutropenia Associated with Radiation... View more |
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy, Neutropenia, Peripheral Progenitor Cell Transplantation, Bone Marrow Transplantation, Neutropenia Associated with Radiation, Hematopoietic... View more |
Related suggestions Bone Marrow Transplantation
Hematopoietic Syndrome of Acute Radiation Syndrome
Popular comparisons
|
|||||||||||||||
| More about Neupogen (filgrastim) | More about Filgrastim | More about Zarxio (filgrastim) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Neupogen has an average rating of 10.0 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Filgrastim has an average rating of 8.0 out of 10 from a total of 10 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 20% reported a negative effect. |
Zarxio has an average rating of 6.8 out of 10 from a total of 4 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 25% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Neupogen side effects |
View all Filgrastim side effects |
View all Zarxio side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Neupogen prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Zarxio prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other filgrastim brands include: Nivestym, Nypozi, Releuko, Zarxio | Neupogen, Nivestym, Nypozi, Releuko, Zarxio | Other filgrastim brands include: Neupogen, Nivestym, Nypozi, Releuko | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
5.8 hours |
5.8 hours |
5.8 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 175 drugs are known to interact with Neupogen:
|
A total of 175 drugs are known to interact with Filgrastim:
|
A total of 175 drugs are known to interact with Zarxio:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
February 20, 1991 |
N/A |
N/A |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
|
||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.